Put companies on watchlist
Galenica AG
ISIN: CH0360674466
WKN: A2DN0K
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Galenica AG · ISIN: CH0360674466 · EQS - Company News (11 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 2072801
23 January 2025 07:00AM

Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors


Galenica AG / Key word(s): Personnel
Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors

23.01.2025 / 07:00 CET/CEST


Press release

Nadine Balkanyi-Nordmann, an experienced legal, compliance and governance expert, will be recommended for election as a member of the Board of Directors at the next Annual General Meeting of the Galenica Group.

At the upcoming Annual General Meeting on 10 April 2025, a new member will be proposed to shareholders for election to the Galenica Board of Directors: Nadine Balkanyi-Nordmann (born in 1972), a recognised leader and expert in various fields of law. This would restore the Board of Directors to seven members.

 

Chairman of the Galenica Board of Directors Markus Neuhaus comments on the nomination: “I am pleased to propose Nadine Balkanyi-Nordmann for election as a new member on behalf of the entire Board of Directors. She is a respected expert in Switzerland in the field of administrative law and risk management and has extensive knowledge of conducting administrative investigations in the public sector, implementing new regulations and developing compliance programmes. In addition, she is a distinguished lawyer and has in-depth knowledge of the healthcare sector.”

 

Leading expert in financial services and healthcare

Nadine Balkanyi-Nordmann is the founder and CEO of Lexperience AG. She has worked for prominent law firms and major financial institutions and has trained at several international institutions. Following her time practising law at Walder Wyss & Partners in Zurich, the Swiss attorney held management positions for various banks such as UBS, GE Capital Bank and BNP Paribas in Asia, America and Switzerland.

 

Nadine Balkanyi-Nordmann studied law at the University of Zurich and was admitted to the Zurich bar. She also holds an LL.M. (Master of Laws) from Hong Kong University. She has extensive knowledge of corporate governance and conducting administrative investigations in the public sector. She is to reinforce the Board of Directors of the Galenica Group with her expertise in integrating ESG criteria when it comes to listed companies and implementing new regulatory requirements.

 

Nadine Balkanyi-Nordmann will not stand for re-election to the Board of Directors of Sanitas in 2025, a position she has held since 2013.

 

Photo of Nadine Balkanyi-Nordmann

Dates for the diary

11 March 2025

Publication of Annual Results of the Galenica Group 2024

10 April 2025

Annual General Meeting of Galenica Ltd.

22 May 2025 Galenica Group sales update

7 August 2025

Publication of Galenica Group half-year results 2025

 

For further information, please contact:

 

Media Relations:
Tel. +41 58 852 85 17
E-Mail:
media@galenica.com
 

Welcome to the Galenica network!
Over 8,000 employees at Galenica work tirelessly to improve the health and well-being of the people of Switzerland every day. With its pharmacies, pharmaceutical logistics providers, products, services and home care, Galenica has a broad and successful position in the market. We are shaping the future of healthcare in collaboration with our strong partners – by drawing on the diverse skills and extensive expertise of our entire network. Our ambition is to fulfil the needs of customers and patients in the Swiss healthcare market seamlessly, efficiently and personally. 

Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information about Galenica can be found at www.galenica.com.



End of Media Release


Language: English
Company: Galenica AG
Untermattweg 8
3027 Bern
Switzerland
Phone: +41 058 852 81 11
E-mail: info@galenica.com
Internet: https://www.galenica.com
ISIN: CH0360674466
Listed: SIX Swiss Exchange
EQS News ID: 2072801

 
End of News EQS News Service

2072801  23.01.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2072801&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Galenica AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.